Sept 15 (Reuters) - Teva Pharmaceuticals can pursue most of its lawsuit accusing rival drugmaker Corcept Therapeutics of monopolizing the market for the mifepristone-based drug Korlym to treat the ...
(RTTNews) - Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), in collaboration with Medincell (MEDCL.PA), announced that the U.S. Food and Drug Administration has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback